{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:36:20Z","timestamp":1791203780447,"version":"4.2.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004885","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T00:00:00Z","timestamp":1216166400000}}],"reference-count":109,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004885.pub2","type":"journal-article","created":{"date-parts":[[2008,6,30]],"date-time":"2008-06-30T07:24:52Z","timestamp":1214810692000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation"],"prefix":"10.1002","volume":"2010","author":[{"given":"Susanne","family":"Quellmann","sequence":"first","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Schwarzer","sequence":"additional","affiliation":[{"name":"German Cochrane Center; Department of Medical Biometry and Statistics; University Medical Center Stefan-Meier-Str. 26 Freiburg Germany D-79104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"H\u00fcbel","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Department I of Internal Medicine, Center of Integrated Oncology K\u00f6ln Bonn; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Greb","sequence":"additional","affiliation":[{"name":"Carl Schurz Strasse 8 Cologne Germany 50935"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bohlius","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,16]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD004885.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1445-5994.1991.tb01406.x","article-title":"A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy","volume":"21","author":"Atkinson","year":"1991","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1083-8791(00)70007-3","article-title":"Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial","volume":"6","author":"Chao","year":"2000","journal-title":"Biology of blood and marrow transplantation : Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD004885.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V89.10.3880","article-title":"Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial","volume":"89","author":"Deeg","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.V96.3.1194a","article-title":"Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial","volume":"96","author":"Deeg","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD004885.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V96.7.2391","article-title":"Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study","volume":"96","author":"Ruutu","year":"2000","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0006|cit6","unstructured":"Ruutu T Volin L Juvonen E Parkkali T Elonen E Nihtinen A Cyclosporine, methotrexate and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: long-term follow-up of a randomized study [abstract] Bone Marrow Transplantation 2003 S138"},{"issue":"5","key":"10.1002\/14651858.CD004885.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","article-title":"What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?","volume":"76","author":"Storb","year":"1990","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Basara N Blau W Kiehl MG Romer E Bischoff M Schmetzer B Mycophenolate mofetil in the treatment and prophylaxis of acute and chronic GVHD in bone marrow transplant patients [abstract] Bone-Marrow-Transplantation 1999 S89","DOI":"10.1034\/j.1399-0012.2000.140204.x"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0009|cit9","unstructured":"Bauser U Kobbe G Hunerliturkoglu A Schneider P Niederste-Hollenberg A Rieth C Acute and chronic graft versus host disease in recipients of allogeneic peripheral blood stem cell transplantion Annals of Hematology 1998 S157"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0010|cit10","unstructured":"Buckner CD Clift RA Appelbaum FR Storb R Petersen FB Sanders JE Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia Bone-Marrow-Transplantation 1991 6 8"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0011|cit11","unstructured":"Elfenbein G Goedert T Graham-Pole J Skoda-Smith S Gross S Weiner R Is prophylaxis against acute graft versus host disease necessary if treatment is effective and survival is not impaired? Proceedings of the American Society of Clinical Oncology [ASCO] 1986"},{"issue":"5","key":"10.1002\/14651858.CD004885.pub2-BIB0012|cit12","first-page":"430","article-title":"[Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors]","volume":"41","author":"Hamazaki","year":"2000","journal-title":"Jpn J Clin Hematol"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0013|cit13","unstructured":"Helenglass G Milliken S Powles R Factors influencing engraftment in cyclosporin (CYA) treated recipients of allogeneic bone marrow transplants (BMT) [abstract] Blood 1987 295a"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0014|cit14","unstructured":"Kraut L Bunjes D Bornhaeuser M Stockschl\u00e4der M Ehninger G Fauser A First results of a multicenter randomized trial on the mycophenolate mofetil in the prophylaxis of graft versus host disease [abstract] Bone Marrow Transplantation 2000 S151"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0015|cit15","first-page":"401","article-title":"Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone","volume":"15","author":"Leelasiri","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0016|cit16","unstructured":"Linck D Schaefer-Eckart K Kroeger M Bornhaeuser M Blau I Wandt H Mycophenolate mofetil in combination with cyclosporine-A (CsA) +\/- prednisolone - the new standard for GvHD prophylaxis? [abstract] Bone Marrow Transplantation 2004 S184"},{"issue":"19","key":"10.1002\/14651858.CD004885.pub2-BIB0017|cit17","first-page":"872","article-title":"[Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia]. [Dutch]","volume":"130","author":"Lowenberg","year":"1986","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0018|cit18","unstructured":"Macedo MCMA PallottaFilho RS Saboya R Silva RL Dzik C Lot\u00e9rio H High-dose steroids, cyclosporine (CSA) and methotrexate (MTX) versus CSA and MTX as prophylaxis of graft-versus-host disease in HLA identical bone marrow transplantation Blood 1997"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0019|cit19","unstructured":"Michallet M Archimbaud E Impact of graft versus host disease (GVHD) prophylactic and therapeutic management on survival and relapse post allogeneic transplant [abstract] Bone Marrow Transplantation 1995 S144"},{"issue":"2","key":"10.1002\/14651858.CD004885.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1701529","article-title":"Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation","volume":"23","author":"Michallet","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"Mohty M Kuentz M Michallet M Bourhis JH Milpied N Sutton L Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study Blood 2002 3128 34","DOI":"10.1182\/blood.V100.9.3128"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0022|cit22","first-page":"174","article-title":"The effect of methyl prednisolone manipulation of bone marrow on engraftment and prevention of graft-versus-host disease [abstract]","volume":"2 Suppl 1","author":"Nandi","year":"1987","journal-title":"Bone Marrow Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD004885.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746","article-title":"Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study","volume":"85","author":"Nash","year":"1995","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0024|cit24","unstructured":"Przepiorka D Ippoliti C Impact of prophylaxis regimen on the incidence of acute graft-versus-host disease after allogeneic blood stem cell transplantation [abstract] Bone Marrow Transplantation 1998 S107"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0025|cit25","unstructured":"Ramsay N Kersey J Robison L Prevention of graft versus host disease (GVHD) in bone marrow transplantation (BMT) recipients: A randomized study Proceedings of the American Association for Cancer Research 1981 676"},{"issue":"6","key":"10.1002\/14651858.CD004885.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood.V84.4.1328.1328","article-title":"Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention","volume":"84","author":"Sayer","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0028|cit28","unstructured":"Schmidt GM Snyder DS Nademanee AP ODonnel MR Parker P Stein A Prospective randomized study: cyclosporin A\/prednisone\/ methotrexate (CSA\/PSE\/MTX) versus CSA\/PSE for the prevention of acute graft versus host disease (GVHD) Blut 1989 218"},{"issue":"Suppl","key":"10.1002\/14651858.CD004885.pub2-BIB0029|cit29","first-page":"845","article-title":"Comparison of cyclosporine (CSP), prednisone (Pred) or alternating-day CSP\/Pred in patients with standard and high-risk chronic graft-versus-host disease (GvHD) [abstract]","volume":"82","author":"Sullivan","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0030|cit30","unstructured":"Tollemar J Ringden O Backman L Janossy G Lonnqvist B Markling L Results of four different protocols for prophylaxis against graft-versus-host disease Transplantation Proceedings 1989 3008 10"},{"issue":"12","key":"10.1002\/14651858.CD004885.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V75.12.2459.2459","article-title":"Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation","volume":"75","author":"Atkinson","year":"1990","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD004885.pub2-BIB0032|cit32","first-page":"755","article-title":"Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation","volume":"16","author":"Atkinson","year":"1995","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004885.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0034|cit34","first-page":"1109","article-title":"Acute graft-versus-host disease","volume-title":"Clinical bone marrow and blood stem cell transplantation","author":"Benesch","year":"2004"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0035|cit35","first-page":"158","article-title":"Preparative Regimens and Modification of Regimen-Related Toxicities","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Bensinger","year":"2004"},{"issue":"8","key":"10.1002\/14651858.CD004885.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bmt.1705488","article-title":"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration","volume":"38","author":"Bensinger","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0037|cit37","first-page":"21","article-title":"The biology of graft-versus-host reactions","volume":"62","author":"Billingham","year":"1966","journal-title":"Harvey Lectures"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0038|cit38","first-page":"449","article-title":"The Evaluation and Counseling of Candidates for Hematopoietic Cell Transplantation","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Blume","year":"2004"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0039|cit39","unstructured":"Bohlius J Expert opinion on in- or exclusion of a study Personal communication 1163"},{"issue":"10","key":"10.1002\/14651858.CD004885.pub2-BIB0040|cit40","first-page":"672","article-title":"Acute graft-versus-host disease","volume":"2","author":"Bolanos-Meade","year":"2004","journal-title":"Clinical Advances in Hematology & Oncology : H&O"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0041|cit41","unstructured":"Brand R Expert opinion on cumulative incidences Personal communication 1142"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.moh.0000148762.05110.56","article-title":"Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease","volume":"12","author":"Burroughs","year":"2005","journal-title":"Current Opinion in Hematology"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2004-11-4557","article-title":"Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study","volume":"106","author":"Cahn","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1705195","article-title":"Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia","volume":"37","author":"Carreras","year":"2006","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1590\/S1516-31801997000300004","article-title":"Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS)","volume":"115","author":"Castro","year":"1997","journal-title":"Sao Paulo Medical Journal\/Revista Paulista de Medicina"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/S1516-31801999000300011","article-title":"Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature database (LILACS database): Update [Letter]","volume":"117","author":"Castro","year":"1999","journal-title":"S\u00e3o Paulo Medical Journal \/ Revista Paulista de Medicina"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0047|cit47","first-page":"209","article-title":"Pharmacology and the Use of Immunosuppressive Agents after Hematopoietic Cell Transplantation","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Chao","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.seminhematol.2005.09.007","article-title":"Prophylaxis and treatment of acute graft-versus-host disease","volume":"43","author":"Chao","year":"2006","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0049|cit49","first-page":"146","article-title":"Infections after HSCT","volume-title":"The EBMT Handbook - Haematopoietic Stem Cell Transplantation","author":"Cordonnier","year":"2004"},{"issue":"9","key":"10.1002\/14651858.CD004885.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.154.9.4719","article-title":"Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes","volume":"154","author":"Cox","year":"1995","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccm.2005.06.016","article-title":"An overview of hematopoietic stem cell transplantation","volume":"26","author":"Cutler","year":"2005","journal-title":"Clinics in Chest Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004885.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.moh.0000208466.63861.9f","article-title":"Transplant strategies for patients with myelodysplastic syndromes","volume":"13","author":"Deeg","year":"2006","journal-title":"Current Opinion in Hematology"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminhematol.2005.09.003","article-title":"The clinical spectrum of acute graft-versus-host disease","volume":"43","author":"Deeg","year":"2006","journal-title":"Seminars in Hematology"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0054|cit54","first-page":"285","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care - Meta-analysis in context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0055|cit55","first-page":"163","article-title":"Graft vs. host disease","volume-title":"The EBMT Handbook - Haematopoietic Stem Cell Transplantation","author":"Devergie","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-004-0611-6","article-title":"Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care","volume":"131","author":"Diaconescu","year":"2005","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"6964","key":"10.1002\/14651858.CD004885.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD004885.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0059|cit59","unstructured":"Elfenbein G Expert opinion on in- or exclusion of a study Personal communication 1161"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.2001.tb03601.x","article-title":"Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect","volume":"938","author":"Feinstein","year":"2001","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0061|cit61","first-page":"353","article-title":"The Pathophysiology of Graft-vs-Host Disease","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Ferrara","year":"2004"},{"issue":"5","key":"10.1002\/14651858.CD004885.pub2-BIB0062|cit62","first-page":"415","article-title":"Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies","volume":"3","author":"Ferrara","year":"2005","journal-title":"Clinical Advances of Hematology & Oncology"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of graft-versus-host disease","volume":"43","author":"Ferrara","year":"2006","journal-title":"Seminars in Hematology"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.beha.2006.11.004","article-title":"Novel strategies for the treatment and diagnosis of graft-versus-host-disease","volume":"20","author":"Ferrara","year":"2007","journal-title":"Best Practice and Research. Clinical Haematology"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","article-title":"Risk factors for acute graft-versus-host disease","volume":"67","author":"Gale","year":"1987","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD004885.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbmt.2004.10.007","article-title":"Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease","volume":"11","author":"Goldberg","year":"2005","journal-title":"Biology of blood and marrow transplantation : Journal of the American Society for Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0068|cit68","first-page":"513","article-title":"Why Kaplan-Meier Fails and Cumulative Incidence Succeeds When Estimating Failure Probabilities in the Presence of Competing Risks","volume-title":"Handbook of Statistics in Clinical Oncology","author":"Gooley","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004885.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V86.2.813.bloodjournal862813","article-title":"Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation","volume":"86","author":"Gratwohl","year":"1995","journal-title":"Blood"},{"issue":"9","key":"10.1002\/14651858.CD004885.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD004885.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bmt.1705104","article-title":"Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"3-4","key":"10.1002\/14651858.CD004885.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/10428199509049763","article-title":"Stimulation tests for the bone marrow neutrophil pool in malignancies","volume":"16","author":"Hansen","year":"1995","journal-title":"Leukemia & Lymphoma"},{"issue":"7414","key":"10.1002\/14651858.CD004885.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0074|cit74","first-page":"9","article-title":"Uses and Growth of Hematopoietic Cell Transplantation","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Horowitz","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graft-versus-host disease","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004885.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00002018-200225020-00002","article-title":"Improving safety reporting from randomised trials","volume":"25","author":"Ioannidis","year":"2002","journal-title":"Drug Safety: an international of medical toxicology and drug experience"},{"issue":"10","key":"10.1002\/14651858.CD004885.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004885.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis","volume":"282","author":"Juni","year":"1999","journal-title":"JAMA"},{"issue":"7303","key":"10.1002\/14651858.CD004885.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0080|cit80","volume-title":"Statistical guidelines for EBMT","author":"Labopin","year":"2005"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0081|cit81","unstructured":"Lefebvre C EMBASE methodological search strategy for OVID Personal communication 17"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0082|cit82","first-page":"5","article-title":"A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetin","volume":"16","author":"Medawar","year":"2004","journal-title":"Int J Risk Saf Med"},{"issue":"9193","key":"10.1002\/14651858.CD004885.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD004885.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-134-8-200104170-00011","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"134","author":"Moher","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"24","key":"10.1002\/14651858.CD004885.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2141.1993.tb04697.x","article-title":"Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods","volume":"83","author":"Pepe","year":"1993","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2141.2005.05614.x","article-title":"Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation","volume":"130","author":"Perez-Simon","year":"2005","journal-title":"British journal of haematology"},{"issue":"6","key":"10.1002\/14651858.CD004885.pub2-BIB0088|cit88","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0089|cit89","first-page":"452","article-title":"Prevention of Acute Graft-Versus-Host Disease","volume-title":"Hematopoietic stem cell therapy","author":"Przepiorka","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD004885.pub2-BIB0090|cit90","first-page":"921","article-title":"Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"18","author":"Ringden","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004885.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0093|cit93","first-page":"1164","article-title":"Nonmyeloablative Therapy and Hematopoietic Cell Transplantation for Hematologic Disorders","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Sandmaier","year":"2004"},{"issue":"17","key":"10.1002\/14651858.CD004885.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004885.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14656566.2.7.1109","article-title":"New developments in the prophylaxis and treatment of graft versus host disease","volume":"2","author":"Simpson","year":"2001","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Socie","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Stem Cell Trialists' Collaborative Group Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials Journal of Clinical Oncology 2005 5074 87 1157","DOI":"10.1200\/JCO.2005.09.020"},{"issue":"1","key":"10.1002\/14651858.CD004885.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1182\/blood.V68.1.119.119","article-title":"Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease","volume":"68","author":"Storb","year":"1986","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD004885.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0100|cit100","first-page":"635","article-title":"Graft-Versus-Host Disease","volume-title":"Thomas' Hematopoietic Cell Transplantation","author":"Sullivan","year":"2004"},{"issue":"27","key":"10.1002\/14651858.CD004885.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","article-title":"Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls","volume":"23","author":"Syrjala","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"17","key":"10.1002\/14651858.CD004885.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts)","volume":"292","author":"Thomas","year":"1975","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004885.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bmt.1705130","article-title":"Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease","volume":"36","author":"Toze","year":"2005","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004885.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clindermatol.2004.06.005","article-title":"Life-threatening graft-vs-host disease","volume":"23","author":"Vargas-Diez","year":"2005","journal-title":"Clinics in Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD004885.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.54.101601.152339","article-title":"Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant","volume":"54","author":"Vogelsang","year":"2003","journal-title":"Annual Review ofMedicine"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0107|cit107","unstructured":"Wheatley K Comments on title registration Personal communication 1146"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0108|cit108","unstructured":"Wheatley K Expert opinion on in- or exclusion of a study Personal communication 1162"},{"key":"10.1002\/14651858.CD004885.pub2-BIB0109|cit109","doi-asserted-by":"crossref","unstructured":"Wingard JR Vogelsang GB Deeg HJ Stem cell transplantation: supportive care and long-term complications Hematology (the education program of the American Society of Hematology) 2002 422 44 82","DOI":"10.1182\/asheducation-2002.1.422"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004885.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T17:46:47Z","timestamp":1762796807000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004885.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,16]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004885.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,16]]}}}